Literature DB >> 25989579

Real-world evidence supports optimally dosed thiazide-type diuretics as preferred in treatment regimens of older adults with hypertension.

Paula T Einhorn1, Paul K Whelton2, Barry R Davis3, Jackson T Wright4, William C Cushman5, Susan J Zieman6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25989579      PMCID： PMC4524522          DOI： 10.1111/jgs.13415

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  10 in total

1.  Diuretics are color blind.

Authors:  James D Neaton; Lewis H Kuller
Journal:  JAMA       Date:  2005-04-06       Impact factor: 56.272

2.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

Review 3.  ALLHAT: still providing correct answers after 7 years.

Authors:  Paula T Einhorn; Barry R Davis; Jackson T Wright; Mahboob Rahman; Paul K Whelton; Sara L Pressel
Journal:  Curr Opin Cardiol       Date:  2010-07       Impact factor: 2.161

4.  Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Authors:  Michael H Alderman; Linda B Piller; Charles E Ford; Jeffrey L Probstfield; Suzanne Oparil; William C Cushman; Paula T Einhorn; Stanley S Franklin; Vasilios Papademetriou; Stephen T Ong; John H Eckfeldt; Curt D Furberg; David A Calhoun; Barry R Davis
Journal:  Hypertension       Date:  2012-03-19       Impact factor: 10.190

5.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

6.  A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

Authors:  Lindon M H Wing; Christopher M Reid; Philip Ryan; Lawrence J Beilin; Mark A Brown; Garry L R Jennings; Colin I Johnston; John J McNeil; Graham J Macdonald; John E Marley; Trefor O Morgan; Malcolm J West
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

7.  Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

Authors:  Bruce M Psaty; Thomas Lumley; Curt D Furberg; Gina Schellenbaum; Marco Pahor; Michael H Alderman; Noel S Weiss
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

8.  ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.

Authors:  Jackson T Wright; Jeffrey L Probstfield; William C Cushman; Sara L Pressel; Jeffrey A Cutler; Barry R Davis; Paula T Einhorn; Mahboob Rahman; Paul K Whelton; Charles E Ford; L Julian Haywood; Karen L Margolis; Suzanne Oparil; Henry R Black; Michael H Alderman
Journal:  Arch Intern Med       Date:  2009-05-11

9.  Treatment of hypertension in patients 80 years of age or older.

Authors:  Nigel S Beckett; Ruth Peters; Astrid E Fletcher; Jan A Staessen; Lisheng Liu; Dan Dumitrascu; Vassil Stoyanovsky; Riitta L Antikainen; Yuri Nikitin; Craig Anderson; Alli Belhani; Françoise Forette; Chakravarthi Rajkumar; Lutgarde Thijs; Winston Banya; Christopher J Bulpitt
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

10.  Risk of thiazide-induced metabolic adverse events in older adults.

Authors:  Anil N Makam; W John Boscardin; Yinghui Miao; Michael A Steinman
Journal:  J Am Geriatr Soc       Date:  2014-05-13       Impact factor: 5.562
  10 in total
  1 in total

1.  Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial.

Authors:  Tara I Chang; Gregory Evans; Alfred K Cheung; William C Cushman; Matthew J Diamond; Jamie P Dwyer; Yonghong Huan; Dalane Kitzman; John B Kostis; Suzanne Oparil; Anjay Rastogi; Christianne L Roumie; Rukmani Sahay; Randall S Stafford; Addison A Taylor; Jackson T Wright; Glenn M Chertow
Journal:  Hypertension       Date:  2016-01-25       Impact factor: 10.190
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.